Need a new search?

If you didn't find what you were looking for, try a new search!

APDN Acquires Assets of DNA Manufacturer Vandalia Research

f Release Details 11 September, 2015 Applied DNA Sciences has acquired the assets of privately held Vandalia Research, Inc. for $1.5 million in cash. . Vandalia’s core technology and intellectual property portfolio, allow for the large-scale production of specific DNA sequences using polymerase chain reaction (PCR). PCR canamplify a few copies of a piece of [...]

By |2022-11-03T12:13:32-04:00September 11th, 2015|Press Release|0 Comments

Applied DNA Schedules Fiscal 2018 Third Quarter Financial Results Conference Call for Monday, August 13, 2018 at 4:30 PM ET

STONY BROOK, N.Y., August 6, 2018 – Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2018 third quarter ended June 30, 2018 after market close on Monday, August 13, 2018. In conjunction with the release, the Company has scheduled a conference call at 4:30 [...]

By |2023-01-25T13:52:54-05:00August 6th, 2018|Press Release|0 Comments

5-Year Supply Agreement for Bulk DNA Manufacturing

STONY BROOK, NY. April 20, 2017 – Applied DNA Sciences, Inc. (“Applied DNA or the Company,” NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, announced that it has entered into an agreement to supply bulk DNA for a leading chemicals company serving the [...]

By |2022-11-02T14:17:26-04:00April 20th, 2017|Press Release|0 Comments

Applied DNA Sciences Enters Diagnostics Market With New DNA Orders

Release Details 2 November, 2015 Applied DNA Sciences, Inc. announced that it has shipped its first orders of DNA used as a diagnostic reagent to reagent suppliers and two international diagnostics customers. The total value of these shipments, which were made in its fiscal 2015 fourth quarter and the current fiscal [...]

By |2022-11-03T10:43:52-04:00November 2nd, 2015|Press Release|0 Comments
Go to Top